Fatal interstitial lung disease after erlotinib administration in a patient with radiation fibrosis.
Um
Soo-Jung
SJ
Department of Internal Medicine, Dong-A University College of Medicine, Busan, Korea.
Lee
Soo-Keol
SK
Yang
Doo Kyung
DK
Son
Choonhee
C
Roh
Mee Sook
MS
Kim
Ki Nam
KN
Lee
Ki-Nam
KN
Choi
Pil Jo
PJ
D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000532:radiotherapy*; D003131:Combined Modality Therapy; D000069347:Erlotinib Hydrochloride; D017809:Fatal Outcome; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000139:chemically induced*; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011799:Quinazolines / Q000009:adverse effects*; D017564:Radiation Pneumonitis / Q000150:complications*
D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride